October 2021. In this study, Head and neck patient-derived fibroblasts were isolated and incorporated into a lymphatic organotypic model. This model provided a platform to identify pathways leading to lymphangiogenesis in each patient, to test anti-angiogenic therapeutics, and to inform therapeutic effectiveness for individual patients.
Read the full article at: https://www.sciencedirect.com/science/article/pii/S2352396421004278?via%3Dihub